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Abstract
Background: The canonical milk-transmitted mouse mammary tumor virus (MMTV) of C3H mice (C3H-MMTV)
rapidly induces tumors in 90% of infected animals by 8 months of age. Pro-viral insertions of C3H-MMTV into
genomic DNA results in the overexpression of common core insertion site (CIS) genes, including Wnt1/10b, Rspo2,
and Fgf3. Conversely, infection by either the endogenous Mtv-1 virus (in C3Hf) or the exogenous nodule-inducing
virus (NIV) (in Balb/c NIV) induces premalignant mammary lesions and tumors with reduced incidence and longer
latency than C3H-MMTV. Here, we asked whether Mtv-1/NIV affected the expression of core CIS genes.
Findings: We confirmed the presence of active virus in Mtv-1/NIV infected tissues and using quantitative reverse
transcription PCR (qRT-PCR) found that Mtv-1/NIV induced neoplasms (tumors and hyperplasia) commonly
expressed the core CIS genes Wnt1, Wnt10b, Rspo2, Fgf3.
Conclusions: These results underscore the importance of core CIS gene expression in the early events leading to
MMTV-induced mammary tumor initiation regardless of the viral variant.
Keywords: Mammary tumorigenesis, Mouse mammary tumor virus, Nodule inducing virus, Mtv-1, Common
integration sites
Findings
The exogenous mouse mammary tumor virus (MMTV)
of C3H mice is transmitted exclusively through the milk
from a mother to her offspring during lactation. Infected
glands develop hyperplasia and tumors, with a 90% mam-
mary tumor incidence by 8 months of age [1-3]. Foster
nursing of C3H pups on mothers from a mouse strain
lacking exogenous virus results in the C3Hf strain of mice.
C3Hf mice developed tumors at a reduced frequency
(20%–40%) and an increased latency (14 to 18 months)
[3-5]. The causative agent of C3Hf neoplasms was identi-
fied as a genetically encoded virus, Mtv-1, also known as
the nodule inducing virus (NIV) [5].
To study the biology of this low tumorigenic virus,
Lawrence Young and colleagues developed the Balb/c
NIV strain by infecting Balb/c mice with NIV through a
complex mammary transplantation protocol [6]. The
result was a milk-transmitted virus that, like the endoge-
nous Mtv-1 in C3Hf mice, produced tumors at lower
frequency and longer latency compared to C3H-MMTV
induced tumors in Balb/c mice. Balb/c NIV induced
mammary epithelial hyperplasia in 95% of aged multipa-
rous tissues. Hyperplastic lesions isolated from Balb/c
NIV and propagated by serial passage in epithelium-free
mammary fat pads of syngeneic females showed mam-
mary tumor incidences at reduced frequency and an
increased latency compared to transplanted hyperplastic
outgrowths resulting from C3H-MMTV infection (50%
versus 100%, and 13.5 months versus 7.7 months,* Correspondence: smithg@mail.nih.gov
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respectively) [6]. Restriction digest analysis of the pro-
viral cDNA sequences of virus isolated from Balb/c NIV
and C3Hf mice revealed differences between the two
viruses’ long-terminal repeat (LTR) sequence; however,
both viruses shared common genetic differences with
C3H-MMTV [7].
Analysis of canonical, highly tumorigenic, MMTV in-
sertions in genomic DNA of tumors and hyperplasia has
identified common integration sites (CIS) [8]. CIS are
regions containing MMTV insertions that affect a par-
ticular gene’s expression, and are found independently
across multiple hyperplasia and tumors. As MMTV in-
serts randomly into the genome during DNA replication,
CIS likely represent critical genetic cancer initiation
events. CIS genes are often deregulated and/or mutated
in human breast cancer samples [9]. Wnt1, Wnt10b,
Rspo2, and Fgf3 have been identified as “core” CIS, as
their up-regulation by MMTV insertions has been
frequently identified in screens across various mouse
and viral strains [8-11]. It should be noted that MMTV
insertions can occur >100 kb from the effected gene,
and the molecular mechanisms of their gene expression
induction may be varied and complex [8-11]. So,
although the precise location of the insertion may vary,
the CIS can be verified by the effect of the insertion on
gene expression.
Table 1 Incidence and latency of mammary tumors in 5 serially passaged premalignant Balb/c outgrowth lines
HOG line Passages (Number of outgrowths) Number of tumors Latency of tumor formation (mos) Percent tumor formation
1 6(24) 9 13.5–22 37.5%
2 6(24) 10 15–22 41.7%
3 23(102) 31 14–22 30.4%
4 11(44) 13 16–22 29.5%
5 8(32) 11 14.5–22 34.4%
Figure 1 Detection of the Mtv-1/NIV virus in Balb/c NIV mammary tumors. (A) PCR amplification of a 3.0 Kb fragment from genomic DNA
isolated from mammary tumors and liver tissues by Polymerase Chain Reaction (PCR) with MMTV (C3H)-specific primers. The MMTV (C3H) 3.0 Kb
PCR product was detected in DNA isolated from Balb/c NIV mammary tumors, C3Hf mammary tumors and C3Hf liver tissue (positive controls) but
not in Balb/c liver. Primers designed to the region 12918–1303 of Chromosome 1 were used as a loading control and to confirm genomic DNA
quality. (B and C) Electron micrographs of ultrathin sections taken from mammary tumors of a C3H (MMTV) (B) and C3Hf (NIV) (C) mice show the
presence of B-type retrovirions are abundant in both tumor types. Micrographs were taken of representative viral particles from ultrathin sections
of OSO4 (osmium teroxide)-fixed tumor tissues, which had been stained with uranyl acetate and lead citrate to enhanced their electron density.
The micrographs were taken on a Philips 300 electron microscope equipped with a camera. Scale bars = 200 nm.
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To determine if the low oncogenic viruses Mtv-1/NIV
affected these same core CIS genes, we analyzed mammary
hyperplasia and tumors in C3Hf and Balb/c NIV mice. All
mice were housed in Association and Accreditation of
Laboratory Animal Care-accredited facilities in accordance
with the NIH Guide for the Care and Use of Laboratory
Animals. The National Cancer Institute Animal Care and
Use Committee approved all experimental procedure.
Breeding pairs of Balb/c NIV mice were a kind gift from
Lawrence Young. From these pairs, we established a co-
lony, and consistent with his findings, we identified tumors
in only 39 out of 102 (38%) retired Balb/c NIV breeders,
and never before the second year of life. From these mice,
we transplanted suspected hyperplastic tissue and es-
tablished 5 independent Balb/c NIV hyperplastic out-
growth (HOG) lines (Table 1). C3Hf tumors were
collected from the Heston colony [3]. We confirmed the
presence of virus by PCR with a primer set that identi-
fies C3H-MMTV and Mtv-1/NIV, but not endogenous
MMTV present within the Balb/c genome (Figure 1A)
[12]. Genomic DNA samples isolated from Balb/c mam-
mary tumors induced by MMTV from Czech mice,
which is unrelated to C3H-MMTV, were also negative
when tested with this primer set (data not shown).
Ultrathin sections from mammary tumors of Balb/c
NIV, C3Hf, and C3H mice were examined under an
electron microscope. Intracellular nucleocapsids, budding
forms, and extracellular retrovirions of the B type were
found abundantly in both tumor types (Figure 1B and C).
Comparison of the viral particles found in canonical milk-
borne MMTV-infected C3H mammary tumors and those
in tumors from C3Hf and Balb/c NIV and C3H-MMTV
were indistinguishable.
Total RNA was isolated from spontaneous tumors and
hyperplastic outgrowths (HOGs) for analysis by quantita-
tive reverse transcription polymerase chain reaction (qRT-
PCR) using validated primers to Wnt1, Wnt10b, Rspo2,
and Fgf3 (SABiosciences/Qiagen, Valencia CA). Table 2
summarizes the samples analyzed, and in all, 5 Balb/c NIV
tumors, 5 Balb/c NIV HOGs, and 6 C3Hf tumors were
assayed. A C3H-MMTV mammary tumor (C3H-MT) was
used as a positive control because of its high expression of
all four genes. Importantly Wnt-1/10b, Rspo2, and Fgf3
are not expressed, or expressed at very low levels in nor-
mal mammary gland [8], and were not detected in preg-
nant mammary or liver control tissues from C3Hf and
Balb/c NIV mice (Figure 2).
However, we found significant expression (p < 0.05 by
one-way analysis of variance (ANOVA) and Dunnett’s
post-hoc comparison of 4 independent reactions of each
sample to control pregnant mammary gland) of all four
genes in C3Hf tumors, Balb/c NIV tumors, and Balb/c
NIV hyperplasia (Tables 2 and 3). All but 5 samples had
significant expression of at least one of the four CIS genes
Table 2 Summary of significance* of expression of core CIS genes Fgf3, Rspo2, Wnt1, and Wnt10b
Sample ID Sample type Fgf3 Wnt1 Wnt10b Rspo2
C3H-MT MMTV (C3H) Mammary Tumor +++ +++ +++ +++
1 Balb/c NIV Mammary Tumor − − ++ +++
2 ++ − ++ +++
3 − − − −
4 − − − ++
5 +++ +++ +++ +++
6 Balb/c NIV Hyperplastic Outgrowth (HOG) + ++ +++ +++
7 − − − −
8 − − − −
9 ++ ++ − +
10 − ++ +++ +++
11 C3Hf NIV Mammary Tumor − − − −
12 − − − ++
13 − − − −
14 − +++ − +++
15 − + − +++
16 − + +++ +++
*Significance of expression was determined by comparing ΔCt values of each sample with normal mammary controls by ANOVA with Dunnett’s post-hoc.
−not significant.
+ p < 0.05.
++ p < 0.01.
+++ p < 0.001.
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(Table 2). In all, 4/16 of the neoplasia expressed Fgf3, 7/16
expressed Wnt-1, 6/16 expressed Wnt10b, and 11/16
expressed Rspo2 (Table 3).
Relative expression of each transcript in every sample
was calculated using the 2-ΔΔCt method. Samples with
expression levels significant above mammary controls
are shown in Figure 2A-D, and plotted as a percentage
of C3H-MT expression. The relative expression varies
greatly from sample to sample, but samples with high
levels of expression approaching, and in some cases
greatly exceeding, that seen in C3H-MT, are present in
all three sample sub-types (Balb/c NIV tumors, hyper-
plasia, and C3Hf tumor). While some samples showed sig-
nificant expression above background, their expression
level was only 1–2% of that seen in the high-expressing
C3H-MT (e.g. sample 10 in Figure 2A, sample 3, 4, 9, 12,
and 13 in Figure 2B). It should be noted, however, that
C3H-MT was chosen for its high expression of all four
genes. It does not represent the average expression seen in
C3H-MMTV induced tumors, which can vary greatly in
the level and amount of CORE CIS genes they express [8].
Furthermore, as these genes are not expressed in normal
mammary tissues, even their relatively low expression
may be of importance.
This is the first demonstration that the low tumori-
genic NIV virus in both C3Hf and Balb/c NIV mice
induces expression of Fgf3, Rspo2, Wnt1, and Wnt10b.
These genes were previously identified as core CIS of ca-
nonical, high tumorigenic MMTV. The induction of the
same genes by a different virus validates the interpret-
ation of MMTV CIS studies, which indicated that the
activation of these genes are important early initiation
events in mammary tumorigenesis. Conversely, these re-
sults also demonstrate that while the inductions of Fgf3,
Rspo2, and/or Wnt-1/10b are important initiation events,
they are not sufficient to induce tumorigenesis. The diffe-
rence in tumorigenic potential of NIV versus canonical
MMTV is likely due to environmental tumor promoting
factors. While the rate of infection and insertion may vary
between the two viruses, this alone cannot account for the
observations presented here as Balb/c NIV mice displayed
Figure 2 Relative expression of core CIS genes in NIV/Mtv-1 induced tumors and hyperplasia. The relative gene expression of Wnt1 (A),
Wnt10b (B), Fgf3 (C), and Rspo2 (D) in individual Balb/c NIV tumors (red), Balb/c NIV hyperplasia (yellow), and C3hf tumors (green) are plotted as
a percentage of expression in a C3H tumor (black). mRNA levels were measured by qRT-PCR and expression was calculated using the 2-ΔΔCt
method. Only samples with significant expression levels above that detected in control mammary glands of Balb/c mice (Table 2) are shown.
Table 3 Summary of the percentage of samples
demonstrating significant* expression of Fgf3, Wnt1,
Wnt10b, and Rspo2
Sample type Fgf3 Wnt1 Wnt10b Rspo2
Balb/c NIV Tumor 2/5 1/5 3/5 4/5
Balb/c NIV Hyperplasia 2/5 3/5 2/5 3/5
C3Hf NIV Tumor 0/6 3/6 1/6 4/6
Total 4/16 7/16 6/16 11/16
* Significance of expression was determined by comparing ΔCt values of each
sample with mammary controls by ANOVA with Dunnett’s post-hoc.
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longer latency in tumor development from hyperplastic
tissue. New insertion events are not required for progres-
sion to tumorigenesis MMTV transformed tissues [8,9],
and here we found that 3/5 HOGs analyzed had signifi-
cant up-regulation of all four transcripts (Table 1 and
Figure 2).
Earlier work indicated that infection with canonical
MMTV resulted in an enhanced response of the host
mammary tissue to exogenous prolactin [13-15]. This
was not seen in C3H mice free of the milk-borne cano-
nical MMTV. Our data suggests that the up-regulation
of the core pathways is important for tumor initiation
even in the absence of canonical MMTV, but progres-
sion to tumor requires promotional events that differ in
mice infected with one or the other virus. Expression of
the MMTV envelope protein in transgenic mice results
in increased side branching and alveolar development in
virgin mice [16]. Furthermore, mutations in the MMTV
envelope protein immunoreceptor tyrosine-based activa-
tion motif (ITAM) attenuate MMTV-induced tumori-
genesis but do not affect the insertion rate of the virus
[16]. Type-specific immunologic differences among the
envelope proteins of C3H-MMTV and NIV/Mtv-1 have
been identified [17,18]; suggesting that variations in the
viral envelope proteins may contribute to the differences
in the latency of tumor development. Importantly,
MMTV derived from Czech mice, which is a tumorigenic
but unique variant of MMTV, has also been shown to
affect the same core CIS [8,9]. Alternatively, differences in
the expression levels of Core CIS genes may exist between
mice infected with low oncogenic and high oncogenic
viruses, however significant differences were not seen in
the hyperplasia or tumors analyzed here with the single
control C3H-MT tumor. Whatever factor(s) causes the
difference in malignant progression, the important finding
is that activation of CORE CIS genes occurs often in pre-
malignant mammary lesions regardless of the MMTV
variant, providing further evidence that the expression of
these genes plays an important role in the early initiation
of mammary oncogenesis.
The unique, low tumorigenic, NIV/Mtv-1 induces
genes identified as core CIS of high tumorigenic
MMTV, despite having a reduced tumorigenic potential.
These results confirm the importance of Fgf3, Wnt-1/
10b, and Rspo2 signaling in mammary tumor initiation,
and the potential role of MMTV variants in tumor
promotion.
Abbreviations
MMTV: Mouse mammary tumor virus; C3H-MMTV: Canonical milk-borne
MMTV of C3H mice; NIV: Nodule inducing virus; Mtv-1: Genetically encoded
endogenous MMTV of C3Hf mice; CIS: Common integration sites;
qRT-PCR: Quantitative reverse transcription polymerase chain reaction;
ITAM: Tyrosine-based activation motif; ANOVA: One-way analysis of variance;
MT: Mammary tumor; C3Hf: C3H mice foster nursed by mothers from a
mouse strain lacking exogenous virus.
Competing interests
The authors disclose no competing interests.
Authors’ contributions
RDB participated in the design of the study and carried out the qRT-PCR
experiments and analysis and drafted the manuscript. SMR carried out the
PCR detection of MMTV and contributed to the drafting of the manuscript.
GHS conceived the study, participated in its design, generated the EM
images and contributed to the drafting of the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
The authors wish to acknowledge the excellent technical help of Adam
Money during his summer internship. This manuscript is dedicated to the
memory of L. J.T. Young whose contributions to this field have been far-
reaching and without whose steadfast interest in mammary tumorigenesis,
this work would not have been possible. The research reported here was
supported in its entirety by the intramural research program of the Center
for Cancer Research at NCI.
Received: 21 March 2013 Accepted: 10 July 2013
Published: 18 July 2013
References
1. Nandi S, McGrath M: Mammary neoplasia in mice. Adv Cancer Res 1973,
17:353–414.
2. Moore D, Long C, Vaidya A, Sheffield J, Dion A, Lasfargues E: Mammary
tumor viruses. Adv Cancer Res 1979, 29:347–418.
3. Heston WE, Vlahakis G: Mammary tumors, plaques, and hyperplastic
alveolar nodules in various combinations of mouse inbred strains and
the different lines of the mammary tumor virus. Int J Cancer 1971,
7:141–148.
4. Moore DH, Holben JA, Charney J: Biologic characteristics of some mouse
mammary tumor viruses. J Natl Cancer Inst 1976, 57:889–896.
5. van Nie R, Verstraeten AA: Studies of genetic transmission of mammary
tumour virus by C3Hf mice. Int J Cancer 1975, 16:922–931.
6. Young LJ, DeOme KB, Blair PB, Pitelka DR, Cardiff RD: Development and
characterization of the BALB/cNIV mouse strain. Cancer Res 1984,
44:4333–4336.
7. Puma JP, Fanning TG, Young LJ, Cardiff RD: Identification of a unique
mouse mammary tumor virus in the BALB/cNIV mouse strain.
J Virol 1982, 43:158–165.
8. Callahan R, Smith GH: Common integration sites for MMTV in viral
induced mouse mammary tumors. J Mammary Gland Biol Neoplasia 2008,
13:309–321.
9. Callahan R, Mudunur U, Bargo S, Raafat A, McCurdy D, Boulanger C,
Lowther W, Stephens R, Luke BT, Stewart C, et al: Genes affected by mouse
mammary tumor virus (MMTV) proviral insertions in mouse mammary
tumors are deregulated or mutated in primary human mammary
tumors. Oncotarget 2012, 3:1320–1334.
10. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J, Hilkens J:
MMTV insertional mutagenesis identifies genes, gene families and
pathways involved in mammary cancer. Nat Genet 2007, 39:759–769.
11. Klijn C, Koudijs MJ, Kool J, Ten Hoeve J, Boer M, de Moes J, Akhtar W, van
Miltenburg M, Vendel-Zwaagstra A, Reinders MJ, et al: Analysis of tumor
heterogeneity and cancer gene networks using deep sequencing of
MMTV-induced mouse mammary tumors. PLoS One 2013, 8:e62113.
12. Boulanger CA, Smith GH: Reducing mammary cancer risk through
premature stem cell senescence. Oncogene 2001, 20:2264–2272.
13. Sinha YN, Salocks CB, Vanderlaan WP, Vlahakis G: Evidence for an influence
of mammary tumour virus on prolactin secretion in the mouse.
J Endocrinol 1977, 74:383–392.
14. Ben-David M, Heston WE, Rodbard D: Mammary tumor virus potentiation
of endogenous prolactin effect on mammary gland differentiation.
J Natl Cancer Inst 1969, 42:207–218.
15. Sinha YN, Selby FW, Vanderlaan WP: The natural history of prolactin and
GH secretion in mice with high and low incidence of mammary tumors.
Endocrinology 1974, 94:757–764.
16. Ross SR, Schmidt JW, Katz E, Cappelli L, Hultine S, Gimotty P, Monroe JG: An
immunoreceptor tyrosine activation motif in the mouse mammary
Bruno et al. Molecular Cancer 2013, 12:79 Page 5 of 6
http://www.molecular-cancer.com/content/12/1/79
tumor virus envelope protein plays a role in virus-induced mammary
tumors. J Virol 2006, 80:9000–9008.
17. Arthur LO, Lovinger GG, Schochetman G: Establishment of a C3Hf
mammary tumor cell line expressing endogenous mouse mammary
tumor virus: antigenic and genetic relationships of this virus with highly
oncogenic mouse mammary tumor viruses. J Virol 1979, 32:852–859.
18. Massey RJ, Arthur LO, Nowinski RC, Schochetman G: Monoclonal
antibodies identify individual determinants on mouse mammary tumor
virus glycoprotein gp52 with group, class, or type specificity. J Virol 1980,
34:635–643.
doi:10.1186/1476-4598-12-79
Cite this article as: Bruno et al.: Late developing mammary tumors and
hyperplasia induced by a low-oncogenic variant of mouse mammary
tumor virus (MMTV) express genes identical to those induced by
canonical MMTV. Molecular Cancer 2013 12:79.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bruno et al. Molecular Cancer 2013, 12:79 Page 6 of 6
http://www.molecular-cancer.com/content/12/1/79
